drug
(ethinylestradiol + norethindrone acetate)
Marketedupdated 4mo agoby Wilshire Pharmaceuticals Inc
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Patent cliff
source: FDA Orange Bookfirst barrier falls
Jul 22, 2027
321 days
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (1)
- Jun 24, 2041formulationUS 12178824
FDA exclusivities (1)
- Jul 22, 2027NPNP321d
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 2h ago
Found something off?
comments(0)
5-min edit window · permanent after that